| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.5 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.5 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.038 | 0.5 |